On the afternoon of August 9, Utkirjon Muysinaliyev, Deputy Governor of Jizzakh Region, Uzbekistan, and Azizjon Ibrohimov, Deputy Head of the Investment and Trade Department of Jizzakh Region, visited Shanghai Unicornshell Technology Co., Ltd. for inspection and exchange. Liu Naiyu, Chairman of Unicornshell, along with his management team, warmly welcomed the delegation and accompanied them on a tour, presenting the company's innovative R&D and industrial layout in the field of HPMC pharmaceutical excipients.

The delegation focused on understanding the technological innovation of HPMC empty capsules, the achievements in the transformation of traditional Chinese medicine (TCM) modernization projects, and the expansion of international markets. In‑depth discussions were held on the need for pharmaceutical industry upgrading in Central Asia. The two sides explored cooperation pathways for the implementation of HPMC pharmaceutical excipient technology under the Belt and Road framework.

Unicornshell focuses on the R&D, production, and sales of HPMC pharmaceutical excipients, having launched hypromellose (HPMC) capsules (first generation) and hydroxypropyl starch capsules (second generation), which are widely used in pharmaceuticals and nutraceuticals, driving the domestic substitution process.

During the visit, Deputy Governor Utkirjon Muysinaliyev highly recognized Unicornshell's R&D capabilities, intelligent manufacturing level, and product quality, and reached a consensus on international cooperation and market expansion. Chairman Liu Naiyu stated that the company will continue to drive development through innovation, strengthen R&D and intelligent manufacturing, promote high‑quality development of the HPMC capsule industry, and meet global health and safety needs for pharmaceuticals.

As an active practitioner of the Belt and Road Initiative, Unicornshell has incorporated the Central Asian market into its global strategic layout. Leveraging its international certifications including US FDA, Halal, Kosher, and European BRC certification, the company has gradually established regional influence. Relying on its technological and intelligent manufacturing strengths in HPMC pharmaceutical excipients, Unicornshell is accelerating the export of advanced processes to Central Asia, helping local areas build their own production systems. This exchange has opened a new path for pharmaceutical industry cooperation between China and Uzbekistan. The two sides will deepen collaboration in technology and localized production, jointly provide safe and environmentally friendly pharmaceutical solutions, and work with global partners to promote technological innovation and market expansion, creating a new international cooperation landscape that is green, safe, and mutually beneficial.